Literature DB >> 5071700

Magnesium deficiency in patients on long-term diuretic therapy for heart failure.

P Lim, E Jacob.   

Abstract

Magnesium levels in serum, erythrocytes, skeletal muscle, and bone were measured in 10 patients with valvular heart disease who had received diuretic therapy for heart failure for an average of 3.3 years. Five patients were found to have diminished values for skeletal muscle, indicating significant magnesium deficit. Values for erythrocytes were low in only two of the five patients, and none had low values for serum ultrafiltrate and bone: Magnesium replacement therapy restored skeletal muscle values to normal. Clinical features consistent with the presence of magnesium deficiency were found in all five magnesium-deficient patients. These features were, with few exceptions, corrected by magnesium replacement. The latter also corrected low skeletal muscle potassium values present in all five patients with low skeletal muscle magnesium, four of whom showed clinical features of digoxin poisoning before magnesium therapy was given. Concomitant secondary aldosteronism, inadequate dietary intake, and digoxin therapy had probably augmented the magnesium loss due to diuretic therapy.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5071700      PMCID: PMC1785918          DOI: 10.1136/bmj.3.5827.620

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  16 in total

1.  EFFECTS OF CARDIAC GLYCOSIDES ON RENAL TUBULAR TRANSPORT OF CALCIUM, MAGNESIUM, INORGANIC PHOSPHATE, AND GLUCOSE IN THE DOG.

Authors:  S KUPFER; J D KOSOVSKY
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

2.  Observations in experimental magnesium depletion.

Authors:  R WHANG; L G WELT
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

3.  Effect of aldosterone on the metabolism of magnesium.

Authors:  R HORTON; E G BIGLIERI
Journal:  J Clin Endocrinol Metab       Date:  1962-12       Impact factor: 5.958

4.  The production of secondary potassium depletion, sodium retention, nephrocalcinosis and hypercalcaemia by magnesium deficiency.

Authors:  I MACINTYRE; D DAVIDSSON
Journal:  Biochem J       Date:  1958-11       Impact factor: 3.857

5.  Magnesium metabolism in infantile protein malnutrition.

Authors:  R D MONTGOMERY
Journal:  Lancet       Date:  1960-07-09       Impact factor: 79.321

6.  Hyperaldosteronism in heart disease.

Authors:  H P WOLFF; K R KOCZOREK; E BUCHBORN
Journal:  Lancet       Date:  1957-07-13       Impact factor: 79.321

7.  Excretion of sodium-retaining substances in patients with congestive heart failure.

Authors:  B SINGER; J WENER
Journal:  Am Heart J       Date:  1953-06       Impact factor: 4.749

8.  Clinical studies of magnesium metabolism.

Authors:  H E MARTIN; J MEHL; M WERTMAN
Journal:  Med Clin North Am       Date:  1952-07       Impact factor: 5.456

Review 9.  Magnesium metabolism.

Authors:  W E Wacker; A F Parisi
Journal:  N Engl J Med       Date:  1968-04-04       Impact factor: 91.245

10.  The acute effects of mersalyl, chlorothiazide and mannitol on the renal excretion of calcium and other ions in man.

Authors:  A M Parfitt
Journal:  Clin Sci       Date:  1969-04       Impact factor: 6.124

View more
  36 in total

1.  Editorial: Calcium, magnesium, and diuretics.

Authors: 
Journal:  Br Med J       Date:  1975-01-25

2.  Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride.

Authors:  L L Ng; M C Garrido; J E Davies; M J Brochwicz-Lewinski; L B Tan
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  Médication et nutrition chez le coronarien.

Authors:  M De Belder
Journal:  Can Fam Physician       Date:  1979-10       Impact factor: 3.275

4.  Intracellular electrolytes in cardiac and skeletal muscle in fatal digitalis intoxication.

Authors:  T Dyckner; U de Faire; P O Wester
Journal:  Br Heart J       Date:  1977-09

5.  Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.

Authors:  Yan Chen; Alex R Chang; Mara A McAdams DeMarco; Lesley A Inker; Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Mayo Clin Proc       Date:  2016-08-04       Impact factor: 7.616

6.  A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.

Authors:  D L Murdoch; G Forrest; D L Davies; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

7.  Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.

Authors:  Y Ambroes; I Ronflette; L Dodion
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction.

Authors:  A M Galløe; H S Rasmussen; L N Jørgensen; P Aurup; S Balsløv; C Cintin; N Graudal; P McNair
Journal:  BMJ       Date:  1993-09-04

Review 9.  Electrolyte abnormalities and ventricular arrhythmias.

Authors:  P V Caralis; E Perez-Stable
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Dose-dependent reduction in renal magnesium clearance by amiloride during frusemide-induced diuresis in rats.

Authors:  J Devane; M P Ryan
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.